Newer Diabetes Meds No Better Than Older, Cheaper Ones

People with diabetes have a multitude of drug options to keep their blood sugar in check from cheap generics that have been around for decades to newer drugs that are pricey to say the least. But the newer drugs are no better at cutting the risk of heart disease, stroke or premature death than the older meds.

Researchers analyzed the results of 301 clinical trials involving more than 120,000 patients. Some of the trials looked at the effectiveness of taking just one diabetes drug, while other examined diabetes therapy with either two or three meds taken together. Overall, 8 different diabetes classes were included.

Interestingly, metformin (also known by brand names Glucophage and Glumetza), a drug that has been around for decades, was better at lowering blood sugar levels than some newer classes of diabetes meds, the researchers reported in the Journal of the American Medical Association.

And as far as extending a person’s life or preventing complications, no single drug or drug combination stood out as better than others.

Recommendations from the American Diabetes Association call for beginning type 2 diabetes treatment with metformin. The study results also showed that metformin has a low risk of hypoglycemia, or a dangerously low drop in blood sugar, compared with other drug classes, especially insulin and sulfonylureas such as Glucotrol (glipizide) and Amaryl (glimepiride).

Metformin is not for everyone, however. Side effects associated with it include gastrointestinal issues such as upset stomach, diarrhea and loss of appetite, as well as muscle pain and sleepiness, causing some patients to discontinue use. People will kidney disease are also advised not to take metformin.

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

Notify of
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…

  • [class^="wpforms-"]